Epidermal growth factor (EGF), oral spray vs placebo
Oral mucositis (moderate to severe) · Adults with cancer receiving treatment
Epidermal growth factor (EGF), oral spray showed no clear difference in oral mucositis (moderate to severe) compared with placebo; GRADE not reported.
2 findings from 1 review
- Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors 2017 · Cochrane All outcomesChemoradiotherapy to the head and neckRR 1.06 [0.78, 1.43]1 study · 136 participantsGRADE not reported
- Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors 2017 · Cochrane All outcomesRadiotherapy to the head and neckRR 0.67 [0.45, 0.99]1 study · 103 participantsGRADE not reported